Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xagrotin in Non-severe COVID-19 Outpatients
NCT05222425Phase 3Unknown
- Sponsor
- Biomad
- Start
- Jun 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Xagrotin in coronavirus disease 2019 (COVID-19), sponsored by Biomad. Status: unknown.
02
Drugs
Xagrotin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05222425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222425.